(Q33474334)

27 July 2017

Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? (English)

1 reference

27 July 2017

0 references

Paul Welsh

3

0 references

Naveed Sattar

1

object named as

Naveed Sattar

1 reference

27 July 2017

13

Rudi G J Westendorp

1 reference

27 July 2017

9

J Wouter Jukema

1 reference

27 July 2017

12

David J Stott

1 reference

27 July 2017

10

Peter W Macfarlane

1 reference

27 July 2017

2

Heather M Murray

1 reference

27 July 2017

8

Gordon D Lowe

1 reference

27 July 2017

7

Anton J M de Craen

1 reference

27 July 2017

6

Stuart Cobbe

1 reference

27 July 2017

15

Ian Ford

1 reference

27 July 2017

Gerard J Blauw

4

1 reference

27 July 2017

Michael B Murphy

11

1 reference

27 July 2017

James Shepherd

14

1 reference

27 July 2017

Chris J Packard

16

1 reference

27 July 2017

Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) Study Group

17

1 reference

27 July 2017

Brendan M Buckley

5

1 reference

27 July 2017

language of work or name

English

0 references

publication date

23 June 2009

1 reference

27 July 2017

1 reference

27 July 2017

6

1 reference

27 July 2017

6

1 reference

27 July 2017

e1000099

1 reference

Creative Commons Attribution 4.0 International

27 July 2017

start time

23 June 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

Leptin and coronary heart disease: prospective study and systematic review

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by rep

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

Combinations of biomarkers predictive of later life mortality

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

Inflammation, atherosclerosis, and coronary artery disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study.

14 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

Biomarkers of inflammation predict both vascular and non-vascular mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

Applying Cox regression to competing risks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

C-reactive protein and all-cause mortality in a large hospital-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

Prediction of Mortality Risk in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)

31 October 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000099

von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694359

C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons

31 October 2018

1 reference

12 December 2020

C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly

1 reference

12 December 2020

Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease

1 reference

12 December 2020

An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study

1 reference

12 December 2020

Does sticky blood predict a sticky end? Associations of blood viscosity, haematocrit and fibrinogen with mortality in the West of Scotland

1 reference

12 December 2020

Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals

1 reference

12 December 2020

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

1 reference

12 December 2020

Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome

1 reference

12 December 2020

Laboratory risk factors for hospital mortality

1 reference

12 December 2020

10.1371/JOURNAL.PMED.1000099

Identifiers

DOI

1 reference

27 July 2017

1 reference

27 July 2017

1 reference